Cargando…

Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study

BACKGROUND/AIM: Milk fat globule-epidermal growth factor 8 (MFG-E8) is expressed in the endometrial epithelium and its expression increases during the implantation process. Due to this knowledge, we aimed to investigate the maternal serum MFG-E8 levels on both healthy pregnant women in the first tri...

Descripción completa

Detalles Bibliográficos
Autores principales: ELÇİ, Bircan, YALÇINKAYA, Zeynep, TEKİN, Ercan, BAKIRCI, Şükrü, DAYANGAN SAYAN, Cemile, KISA, Üçler, KURDOĞLU, Mertihan, ÖZKAN, Zehra Sema, SAĞSÖZ, Nevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388033/
https://www.ncbi.nlm.nih.gov/pubmed/37476868
http://dx.doi.org/10.55730/1300-0144.5614
_version_ 1785082019644964864
author ELÇİ, Bircan
YALÇINKAYA, Zeynep
TEKİN, Ercan
BAKIRCI, Şükrü
DAYANGAN SAYAN, Cemile
KISA, Üçler
KURDOĞLU, Mertihan
ÖZKAN, Zehra Sema
SAĞSÖZ, Nevin
author_facet ELÇİ, Bircan
YALÇINKAYA, Zeynep
TEKİN, Ercan
BAKIRCI, Şükrü
DAYANGAN SAYAN, Cemile
KISA, Üçler
KURDOĞLU, Mertihan
ÖZKAN, Zehra Sema
SAĞSÖZ, Nevin
author_sort ELÇİ, Bircan
collection PubMed
description BACKGROUND/AIM: Milk fat globule-epidermal growth factor 8 (MFG-E8) is expressed in the endometrial epithelium and its expression increases during the implantation process. Due to this knowledge, we aimed to investigate the maternal serum MFG-E8 levels on both healthy pregnant women in the first trimester and pregnant women complicated with missed abortion and threatened abortion in the first trimester. MATERIALS AND METHODS: This prospective, cross-sectional study was conducted in a tertiary referral hospital, department of obstetrics between July 2020 and February 2021 after ethical committee approval. The study population was consisted of 30 healthy pregnant women (HP) in the first trimester, 30 pregnant women suffering from threatened abortion (TA) in the first trimester and 30 pregnant women suffering from missed abortion (MA) in the first trimester. Maternal serum MFG-E8 levels were analyzed with enzyme linked immunosorbent assay. Delivery and neonatal outcomes of the study population was evaluated. The continuous variables were compared among three groups with variance analysis with post hoc tests. The categorical variables were compared with chi-square and Fisher’s exact tests where applicable. RESULTS: The mean age of the study population was 29.36 ± 5.31 years. There was no significant difference among three groups for parameters of age, body mass index, parity number, and gestational week. Despite being within normal ranges, the mean neutrophil and international normalized ratio values of the three groups showed statistically significant difference (p < 0.05). The mean maternal serum MFG-E8 levels of MA, TA, and HP groups were 270 ± 152.3, 414.7 ± 236.7, and 474 ± 222.5 ng/mL, respectively (p = 0.001). It was found that mean of MFG-E8 of the MA group was statistically significantly lower than those of the other two groups (p < 0.05). CONCLUSION: Although maternal serum MFG-E8 level seems to be a parameter that differ between live and nonlive pregnancies, studies with large number of cases are needed to discuss our results and to determine a cut-off value for prediction
format Online
Article
Text
id pubmed-10388033
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Scientific and Technological Research Council of Turkey (TUBITAK)
record_format MEDLINE/PubMed
spelling pubmed-103880332023-08-01 Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study ELÇİ, Bircan YALÇINKAYA, Zeynep TEKİN, Ercan BAKIRCI, Şükrü DAYANGAN SAYAN, Cemile KISA, Üçler KURDOĞLU, Mertihan ÖZKAN, Zehra Sema SAĞSÖZ, Nevin Turk J Med Sci Research Article BACKGROUND/AIM: Milk fat globule-epidermal growth factor 8 (MFG-E8) is expressed in the endometrial epithelium and its expression increases during the implantation process. Due to this knowledge, we aimed to investigate the maternal serum MFG-E8 levels on both healthy pregnant women in the first trimester and pregnant women complicated with missed abortion and threatened abortion in the first trimester. MATERIALS AND METHODS: This prospective, cross-sectional study was conducted in a tertiary referral hospital, department of obstetrics between July 2020 and February 2021 after ethical committee approval. The study population was consisted of 30 healthy pregnant women (HP) in the first trimester, 30 pregnant women suffering from threatened abortion (TA) in the first trimester and 30 pregnant women suffering from missed abortion (MA) in the first trimester. Maternal serum MFG-E8 levels were analyzed with enzyme linked immunosorbent assay. Delivery and neonatal outcomes of the study population was evaluated. The continuous variables were compared among three groups with variance analysis with post hoc tests. The categorical variables were compared with chi-square and Fisher’s exact tests where applicable. RESULTS: The mean age of the study population was 29.36 ± 5.31 years. There was no significant difference among three groups for parameters of age, body mass index, parity number, and gestational week. Despite being within normal ranges, the mean neutrophil and international normalized ratio values of the three groups showed statistically significant difference (p < 0.05). The mean maternal serum MFG-E8 levels of MA, TA, and HP groups were 270 ± 152.3, 414.7 ± 236.7, and 474 ± 222.5 ng/mL, respectively (p = 0.001). It was found that mean of MFG-E8 of the MA group was statistically significantly lower than those of the other two groups (p < 0.05). CONCLUSION: Although maternal serum MFG-E8 level seems to be a parameter that differ between live and nonlive pregnancies, studies with large number of cases are needed to discuss our results and to determine a cut-off value for prediction Scientific and Technological Research Council of Turkey (TUBITAK) 2023-01-15 /pmc/articles/PMC10388033/ /pubmed/37476868 http://dx.doi.org/10.55730/1300-0144.5614 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
ELÇİ, Bircan
YALÇINKAYA, Zeynep
TEKİN, Ercan
BAKIRCI, Şükrü
DAYANGAN SAYAN, Cemile
KISA, Üçler
KURDOĞLU, Mertihan
ÖZKAN, Zehra Sema
SAĞSÖZ, Nevin
Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study
title Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study
title_full Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study
title_fullStr Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study
title_full_unstemmed Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study
title_short Could maternal serum MFG-E8 level predict adverse first trimester pregnancy outcome? A preliminary study
title_sort could maternal serum mfg-e8 level predict adverse first trimester pregnancy outcome? a preliminary study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388033/
https://www.ncbi.nlm.nih.gov/pubmed/37476868
http://dx.doi.org/10.55730/1300-0144.5614
work_keys_str_mv AT elcibircan couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT yalcinkayazeynep couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT tekinercan couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT bakircisukru couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT dayangansayancemile couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT kisaucler couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT kurdoglumertihan couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT ozkanzehrasema couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy
AT sagsoznevin couldmaternalserummfge8levelpredictadversefirsttrimesterpregnancyoutcomeapreliminarystudy